tiprankstipranks
Trending News
More News >
Strides Pharma Science Ltd (IN:STAR)
:STAR
India Market
Advertisement

Strides Pharma Science Ltd (STAR) Ratios

Compare
1 Followers

Strides Pharma Science Ltd Ratios

IN:STAR's free cash flow for Q4 2025 was ₹0.59. For the 2025 fiscal year, IN:STAR's free cash flow was decreased by ₹ and operating cash flow was ₹0.15. See a summary of the company’s cash flow.
Ratios
TTM
Mar 25Mar 24Mar 23Mar 22
Liquidity Ratios
Current Ratio
1.20 1.03 1.08 0.99 0.99
Quick Ratio
0.70 0.64 0.70 0.64 0.64
Cash Ratio
0.05 0.06 0.10 0.05 0.05
Solvency Ratio
0.15 0.04 <0.01 -0.05 -0.05
Operating Cash Flow Ratio
0.00 0.24 0.01 -0.08 -0.08
Short-Term Operating Cash Flow Coverage
0.00 0.40 0.03 -0.13 -0.13
Net Current Asset Value
₹ -3.63B₹ -7.99B₹ -12.22B₹ -12.28B₹ -12.28B
Leverage Ratios
Debt-to-Assets Ratio
0.31 0.43 0.46 0.43 0.43
Debt-to-Equity Ratio
0.74 1.18 1.37 1.28 1.28
Debt-to-Capital Ratio
0.42 0.54 0.58 0.56 0.56
Long-Term Debt-to-Capital Ratio
0.18 0.24 0.34 0.26 0.26
Financial Leverage Ratio
2.37 2.75 3.00 2.96 2.96
Debt Service Coverage Ratio
0.56 0.17 0.29 0.02 0.02
Interest Coverage Ratio
2.58 1.66 -0.31 -1.94 -1.94
Debt to Market Cap
0.21 0.33 1.08 0.90 0.90
Interest Debt Per Share
232.75 311.13 365.31 353.30 353.30
Net Debt to EBITDA
1.90 6.26 5.42 -21.21 -21.21
Profitability Margins
Gross Profit Margin
47.72%55.66%55.89%47.61%47.61%
EBIT Margin
15.34%4.00%7.05%-12.08%-12.08%
EBITDA Margin
19.74%9.68%13.63%-4.45%-4.45%
Operating Profit Margin
14.74%13.43%-2.16%-9.35%-9.35%
Pretax Profit Margin
9.30%-3.01%-7.76%-21.59%-21.59%
Net Profit Margin
7.18%-1.81%-6.26%-15.69%-15.69%
Continuous Operations Profit Margin
7.27%-3.82%-6.26%-15.69%-15.69%
Net Income Per EBT
77.20%60.38%80.68%72.68%72.68%
EBT Per EBIT
63.11%-22.38%359.10%231.04%231.04%
Return on Assets (ROA)
5.51%-1.21%-3.48%-6.80%-6.80%
Return on Equity (ROE)
14.65%-3.32%-10.44%-20.10%-20.10%
Return on Capital Employed (ROCE)
19.80%17.65%-2.18%-7.92%-7.92%
Return on Invested Capital (ROIC)
11.74%14.02%-1.21%-3.69%-3.69%
Return on Tangible Assets
6.76%-1.48%-4.15%-8.09%-8.09%
Earnings Yield
3.99%-0.97%-8.95%-15.25%-15.25%
Efficiency Ratios
Receivables Turnover
3.86 3.41 2.84 -1.17K -1.17K
Payables Turnover
2.35 2.03 1.66 1.48 1.48
Inventory Turnover
1.90 1.53 1.42 1.35 1.35
Fixed Asset Turnover
4.74 3.98 2.69 2.00 2.00
Asset Turnover
0.77 0.67 0.56 0.43 0.43
Working Capital Turnover Ratio
18.31 22.69 35.83 176.74 176.74
Cash Conversion Cycle
131.37 165.22 165.42 23.27 23.27
Days of Sales Outstanding
94.53 107.11 128.59 -0.31 -0.31
Days of Inventory Outstanding
192.04 238.28 257.22 270.60 270.60
Days of Payables Outstanding
155.20 180.17 220.39 247.02 247.02
Operating Cycle
286.58 345.40 385.81 270.29 270.29
Cash Flow Ratios
Operating Cash Flow Per Share
0.00 77.04 4.93 -28.73 -28.73
Free Cash Flow Per Share
0.00 64.06 -5.61 -44.70 -44.70
CapEx Per Share
0.00 12.98 10.54 15.98 15.98
Free Cash Flow to Operating Cash Flow
0.00 0.83 -1.14 1.56 1.56
Dividend Paid and CapEx Coverage Ratio
0.00 5.32 0.47 -1.55 -1.55
Capital Expenditure Coverage Ratio
0.00 5.93 0.47 -1.80 -1.80
Operating Cash Flow Coverage Ratio
0.00 0.28 0.01 -0.09 -0.09
Operating Cash Flow to Sales Ratio
0.00 0.18 0.01 -0.09 -0.09
Free Cash Flow Yield
0.00%7.97%-1.96%-12.90%-12.90%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
25.03 -103.52 -11.17 -6.56 -6.56
Price-to-Sales (P/S) Ratio
1.80 1.88 0.70 1.03 1.03
Price-to-Book (P/B) Ratio
3.27 3.44 1.17 1.32 1.32
Price-to-Free Cash Flow (P/FCF) Ratio
0.00 12.54 -51.05 -7.75 -7.75
Price-to-Operating Cash Flow Ratio
0.00 10.43 58.08 -12.07 -12.07
Price-to-Earnings Growth (PEG) Ratio
1.06 1.48 0.22 0.02 0.02
Price-to-Fair Value
3.27 3.44 1.17 1.32 1.32
Enterprise Value Multiple
11.01 25.67 10.55 -44.33 -44.33
Enterprise Value
100.95B 96.66B 53.06B 59.65B 59.65B
EV to EBITDA
11.01 25.67 10.55 -44.33 -44.33
EV to Sales
2.17 2.48 1.44 1.97 1.97
EV to Free Cash Flow
0.00 16.58 -105.00 -14.87 -14.87
EV to Operating Cash Flow
0.00 13.79 119.46 -23.14 -23.14
Tangible Book Value Per Share
159.74 111.56 121.67 141.78 141.78
Shareholders’ Equity Per Share
276.93 233.57 245.59 262.87 262.87
Tax and Other Ratios
Effective Tax Rate
0.19 -0.27 0.19 0.27 0.27
Revenue Per Share
504.05 427.58 409.45 336.73 336.73
Net Income Per Share
36.20 -7.76 -25.63 -52.84 -52.84
Tax Burden
0.77 0.60 0.81 0.73 0.73
Interest Burden
0.61 -0.75 -1.10 1.79 1.79
Research & Development to Revenue
0.00 0.00 0.02 0.03 0.03
SG&A to Revenue
0.00 0.04 0.04 0.05 0.05
Stock-Based Compensation to Revenue
0.00 <0.01 <0.01 >-0.01 >-0.01
Income Quality
0.00 -11.18 -0.17 0.40 0.40
Currency in INR
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis